Labrafil M 2130 Cs
ExcipientUNII 8EPU9MJ01K
1 organisation holds 1 active FDA Type IV Drug Master File for Labrafil M 2130 Cs.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology
Active Type IV DMFs (1)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| GATTEFOSSE SAS France | 5182 | LABRAFIL M 2130 CS | Oct 1983 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Labrafil M 2130 Cs.
For suppliers
Do you supply Labrafil M 2130 Cs?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.